Japan Clinical Trial Equipment & Ancillary Solutions Market Size & Outlook
Related Markets
Japan clinical trial equipment & ancillary solutions market highlights
- The Japan clinical trial equipment & ancillary solutions market generated a revenue of USD 221.1 million in 2024 and is expected to reach USD 532.4 million by 2033.
- The Japan market is expected to grow at a CAGR of 10.3% from 2025 to 2033.
- In terms of segment, supply/logistics was the largest revenue generating type in 2024.
- Supply/Logistics is the most lucrative type segment registering the fastest growth during the forecast period.
Clinical trial equipment & ancillary solutions market data book summary
| Market revenue in 2024 | USD 221.1 million |
| Market revenue in 2033 | USD 532.4 million |
| Growth rate | 10.3% (CAGR from 2025 to 2033) |
| Largest segment | Supply/logistics |
| Fastest growing segment | Supply/Logistics |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sourcing, Supply/Logistics, Service |
| Key market players worldwide | Woodley Equipment Company, PAREXEL, Thermo Fisher Scientific Inc, Cadila Pharmaceuticals, United Parcel Service Inc Class B, Ancillare, Imperial CRS, Emser, Quipment, Myonex, Yourway |
Other key industry trends
- In terms of revenue, Japan accounted for 6.9% of the global clinical trial equipment & ancillary solutions market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China clinical trial equipment & ancillary solutions market is projected to lead the regional market in terms of revenue in 2033.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 105.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Equipment & Ancillary Solutions Market Scope
Clinical Trial Equipment & Ancillary Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Yourway | View profile | 51-100 | Allentown, Pennsylvania, United States, North America | http://www.yourway.com |
| Myonex | View profile | 101-250 | Horsham, Pennsylvania, United States, North America | https://www.myonex.com/ |
| Quipment | View profile | 51-100 | Nancy, Lorraine, France, Europe | https://www.quipment.fr |
| Emser | View profile | 51-100 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.emsere.com |
| Imperial CRS | View profile | 251-500 | Grand Rapids, Michigan, United States, North America | http://www.imperialcrs.com |
| Ancillare | View profile | 251-500 | Horsham, Pennsylvania, United States, North America | https://www.ancillare.com |
| Cadila Pharmaceuticals | View profile | 5001-10000 | Ahmedabad, Gujarat, India, Asia | http://cadilapharma.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| United Parcel Service Inc Class B | View profile | 500000 | 55 Glenlake Parkway, N.E. Atlanta, Atlanta, GA, United States, 30328 | https://www.ups.com |
| Woodley Equipment Company | View profile | 101-250 | Bolton, Bolton, United Kingdom, Europe | http://www.woodleyequipment.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Japan clinical trial equipment & ancillary solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial equipment & ancillary solutions market will help companies and investors design strategic landscapes.
Supply/logistics was the largest segment with a revenue share of 37.13% in 2024. Horizon Databook has segmented the Japan clinical trial equipment & ancillary solutions market based on sourcing, supply/logistics, service covering the revenue growth of each sub-segment from 2021 to 2033.
Hence, repairing damaged organ, replacing damaged organs with stem-cells, and developing better cost-efficient medicines are incorporated in their vision. Japan is an attractive market for outsourcing for developed nations such as the U.S. The regulatory process is also supportive of faster clinical trial approval.
For instance, clinical trials can be started once the probable benefits are demonstrated by carrying out relatively smaller number of clinical trials. Furthermore, international CROs are acquiring Japanese market players to expand their reach to clinical trial services.
For instance, in March 2022, MCRA, LLC, a CRO, announced the acquisition of Vorpal Technologies K.K. to further expand its operations in Japan. Furthermore, clinical trials studies conducted for the therapeutic area, oncology, has captured 33.7% share, CNS held around 11.6% share, and infectious disease held around 9.8% share in 2020.
Reasons to subscribe to Japan clinical trial equipment & ancillary solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan clinical trial equipment & ancillary solutions market databook
-
Our clientele includes a mix of clinical trial equipment & ancillary solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan clinical trial equipment & ancillary solutions market , including forecasts for subscribers. This country databook contains high-level insights into Japan clinical trial equipment & ancillary solutions market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Japan clinical trial equipment & ancillary solutions market size, by type, 2021-2033 (US$M)
Japan Clinical Trial Equipment & Ancillary Solutions Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
